Lapatinib in Treating Patients With Prostate Cancer That Did Not Respond to Hormone Therapy
Status:
Completed
Trial end date:
2013-05-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Lapatinib may stop the growth of tumor cells by blocking some of the enzymes
needed for cell growth.
PURPOSE: This phase II trial is studying how well lapatinib works in treating patients with
prostate cancer that did not respond to hormone therapy.